Vladimir Vuksan, John L Sievenpiper, Elena Jovanovski, Alexandra L Jenkins, Allison Komishon, Fei Au-Yeung, Andreea Zurbau, Hoang V T Ho, Dandan Li, Lea Smircic-Duvnjak
Journal: Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2021;45(7):801-804
PMID: 32213141
We applied the Framingham risk equation in healthy, metabolic syndrome, and diabetes populations, following treatment with viscous fibre from konjac-based blend (KBB). KBB yielded reduction in estimated risk score by 16% (1.04 ± 0.03 vs. 0.87 ± 0.04, < 0.01) in type 2 diabetes, 24% (1.08 ± 0.01 vs. 0.82 ± 0.02, < 0.01) in metabolic syndrome, and 25% (1.09 ± 0.05 vs. 0.82 ± 0.06, < 0.01) in healthy individuals. Drivers for decreased risk were improvements in blood cholesterol and systolic blood pressure. The composite coronary heart disease risk across populations was reduced 22% ( < 0.01). Viscous fibre from konjac-xanthan reduced 10-year relative coronary heart disease using Framingham Risk Score across the glycemic status spectrum.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.